Invariant natural killer T cells (iNKT cells) have a semi-invariant
T cell antigen receptor composed of α-and β-chains (αβTCR) and recognize lipid antigens presented by CD1d 1 . Unlike adaptive T cells restricted by major histocompatibility complex (MHC), they display an effector and memory phenotype at steady-state, which renders them poised for immediate effector function. Because of their rapid response and basal expression of NK cell receptors, they are considered 'innate' T cells. iNKT cells characteristically have high expression of the bric-a-bric, tramtrack, broad complex-poxvirus zinc finger transcription factor PLZF (encoded by Zbtb16), which was initially proposed to define the iNKT cell lineage 2, 3 . PLZF is also expressed by human mucosa-associated invariant T cells 4 , another population of semi-invariant T cells, as well as an innate subset of γδ T cells 5 . Thus, expression of PLZF is associated with T cells with limited TCR diversity and is thought to be responsible for the innate phenotype and rapid cytokine response of these cells 5 .
MHC-restricted CD4 + T cells differentiate into the T H 1, T H 2, T H 17 subsets of helper T cells and regulatory T cells (T reg cells)
. Likewise, subpopulations of iNKT cells analogous to T H 1, T H 2, T H 17 cells have been found, and they express some of the same transcription factors that the corresponding MHC-restricted T cell subsets express. Surface markers such as CD4, NK1.1 and IL-17RB (a component of the receptor for interleukin ) and cytokine receptors such as IL-12R
and IL-23R can distinguish T H 1-like, T H 2-like and T H 17-like iNKT cell functional subsets 6, 7 . However, iNKT cells can produce both T H 1 cytokines and T H 2 cytokines simultaneously, and functionally, while many iNKT cells are inflammatory and have important roles in host defense, they are also linked to the prevention or control of autoimmune disease 8 . The production of IL-4, IL-10 and IL-13 by iNKT cells has been linked to their ability to suppress cell-mediated immune responses 9 . iNKT cell numbers are reduced in humans with autoimmune diseases and mouse models of autoimmunity such as type I diabetes 10 , multiple sclerosis 11, 12 and systemic lupus erythematosus 13 , and exacerbation or prevention of these conditions is seen in the absence of iNKT cells or following activation of iNKT cells, respectively 14 . However, a T reg cell-like regulatory subset of iNKT cells has not been found.
In both mice and humans, visceral adipose tissue shows considerable enrichment for iNKT cells; in this tissue, they represent 15-20% of total T cells 15, 16 . Adipose tissue harbors a distinct collection of cells of the immune system not seen elsewhere. Alternatively activated (M2) macrophages have an important role in the homeostasis of the adipose tissue in the lean state 17 . T reg cells with restricted TCR use 18 and a distinct gene-expression profile that includes expression of the gene encoding the transcription factor PPAR-γ and high expression of IL-10 (ref. 19 ) accumulate in adipose tissue with age 18 . However, A r t i c l e s the development of obesity brings major changes to the immunological repertoire of adipose tissue. iNKT cell numbers decrease early in human and mouse obesity 15, 16, [20] [21] [22] . Likewise, there is a drop in adipose T reg cell numbers 18 , while macrophages accumulate 23 and undergo a phenotypic switch to the M1 proinflammatory macrophage type, in adipose tissue in the obese state 24 . These changes result in a state of chronic inflammation that contributes to metabolic disease through inflammation-induced insulin resistance.
It has been reported that iNKT cells in adipose tissue serve a protective role against obesity-induced inflammation, glucose intolerance and weight gain through regulatory cytokine production 16, 20, 22, [25] [26] [27] . However, the basis for the protective function and the anti-inflammatory nature of iNKT cells in adipose tissue compared with that of the T H 1, T H 2 and T H 17 inflammatory iNKT cells in other locations is not understood. Here we found that iNKT cells in adipose tissue displayed a transcriptome different from that of iNKT cells in other locations and were most notably characterized by the lack of PLZF expression. Mice deficient in iNKT cells had fewer T reg cells in adipose tissue than wild-type mice had, and we found that iNKT cells transactivated adipose T reg cells and regulated their function. iNKT cells in adipose tissue also produced IL-10 in a manner dependent on the transcription factor E4BP4 and were able to induce an M2 phenotype in macrophages. Thus, we define a previously unknown subpopulation of regulatory iNKT cells with the ability to regulate the function of macrophages and T reg cells in adipose tissue.
RESULTS i NKT cells in adipose tissue are tissue resident
Human and mouse adipose tissue shows enrichment for iNKT cells; in this tissue, their expression of CD4 and NK1.1 is less than that on iNKT cells elsewhere in the periphery 15, 16 . To learn more about the nature of iNKT cells in visceral adipose tissue, we investigated whether they are constantly replenished from the periphery or if they represent a tissue-resident population. To address this, we generated parabiotic pairs of CD45.1 + and CD45.2 + congenic mice. During the healing process after surgery, capillary anastomoses form between the two vascular systems, which allows the exchange of circulating peripheral blood cells. In this experimental system, MHC-restricted CD4 + and CD8 + T cells and B cells rapidly recirculated to reach equilibrium (equal chimerism) in the blood and spleen of parabiotic mice after 2 weeks (Fig. 1a) , while progenitors and bone marrow and thymic cells do not exchange at this time 28 . However, the parabiotic reconstitution was lower in the liver and adipose tissue (Fig. 1a) , which suggested resident lymphocyte populations with low turnover resided in these locations. To identify the circulating or resident activity of each lymphocyte population, we examined the chimerism of various lymphocyte subsets. B cells, CD8 + T cells and CD4 + T cells recirculated though blood, spleen, liver and adipose tissue, reaching almost equal (50%) chimerism between CD45.1 + and CD45.2 + (Fig. 1b) , indicative of nearly complete exchange. Adipose T reg cells recirculated to a lesser degree, with only 25% of cells originating from the parabiotic partner of each mouse, although we saw almost complete chimerism of T reg cells in the blood, spleen and liver (Fig. 1b) . This suggested that T reg cells constantly recirculated through some organs but also made up resident populations in selected tissues. In contrast to all the other lymphocyte populations, iNKT cells showed almost no circulation in any of the organs examined (Fig. 1b) . In adipose tissue, >95% of iNKT cells were derived from the host (Fig. 1b,c) , which indicated that iNKT cells were a tissue-resident lymphocyte population in adipose tissue.
Because interactions between integrin α L β 2 (LFA-1) and its ligand ICAM-1 for are critical for the retention of iNKT cells in the liver [29] [30] [31] we investigated if LFA-1 and ICAM-1 were responsible for the accumulation and retention of iNKT cells in adipose tissue. ICAM-1-deficient mice with targeted null mutation of the gene encoding ICAM-1 had fewer iNKT cells in the liver than wild-type mice had (Fig. 1d,e) , which confirmed the importance of ICAM-1 in the retention of hepatic iNKT cells. However, iNKT cells were present at a normal to slightly elevated frequency and a similar absolute number in the adipose tissue of ICAM-1-deficient mice relative to their abundance in the adipose tissue of wild-type mice (Fig. 1d,e) . Furthermore, in vivo blockade of ICAM-1 and LFA-1 with neutralizing antibodies resulted in the egress of iNKT cells from the liver but not from adipose tissue (Fig. 1f) . Thus, adipose iNKT cells were a tissue-resident population that did not rely on ICAM-1-LFA-1 interactions for their retention in adipose tissue.
Unique gene-expression program of adipose i NKT cells iNKT cells in adipose tissue have phenotypical and functional characteristics different from those of other iNKT cells, including low expression of CD4 and NK1.1, low production of interferon-γ (IFN-γ) and production of 20) , which, together with the observation that they were tissue resident, would suggest that they might represent a unique population. High-resolution expression analysis comparing iNKT cells with other leukocyte populations, as well as iNKT cells in various tissues, as part of the Immunological Genome Project, has revealed that iNKT cells from liver, spleen and thymus differ in the expression of only a small number of genes (for example, liver and splenic iNKT cells differ in the expression of ~100 genes) 32 . Microarray gene-expression analysis of iNKT cells in visceral adipose tissue revealed that adipose iNKT cells overexpressed 639 genes compared with the expression of those genes in splenic iNKT cells from the same mice (Fig. 2a) , which suggested that they might represent a distinct iNKT cell population. The overexpressed genes included those encoding the mitogen-activated protein kinase phosphatase Dusp1 (Dusp1), the nuclear receptor and transcription factor Nur77 (Nr4a1) and the basic leucine zipper transcription factor E4BP4 (Nfil3) (Fig. 2a) . In addition, expression of 2,710 genes was under-represented in adipose iNKT cells compared with their expression in splenic iNKT cells (Fig. 2a) . The gene encoding PLZF (Zbtb16), a transcription factor reported to be expressed by all iNKT cells examined up to now 2,3 , was not substantially expressed by adipose iNKT cells, and IL-7R was also not expressed on adipose iNKT cells (Fig. 2a) . In contrast, Zbtb16 had high expression in splenic iNKT cells (Fig. 2a) , similar to published reports for hepatic, splenic and thymic iNKT cells 3, 5, 32 . The expression of PLZF transcripts was just above the expression cutoff point in adipose iNKT cells (Fig. 2b) . To analyze the expression of PLZF protein in iNKT cells in adipose tissue, we used PLZF-GFP reporter mice generated through the use of a modified bacterial artificial chromosome transgene expressing enhanced green fluorescent protein (GFP) under the control of regulatory elements of Zbtb16. Flow cytometry revealed that iNKT cells in adipose tissue had very low GFP expression, while iNKT cells in liver and thymus were GFP + (Fig. 2c) . We next investigated whether iNKT cells in adipose tissue in young mice expressed PLZF. The youngest age at which we could detect epididymal adipose tissue in mice was ~12 d (data not shown), a time at which it is thought that iNKT cells start to populate the periphery 33 . iNKT cells were first detectable in mouse adipose tissue at 2 weeks of age, and they increased in abundance with age to represent 5% of T cells at 2 weeks and ~20% of T cells at 16 weeks (Fig. 2d) . However, adipose iNKT cells in 2-week-old npg PLZF-GFP mice had low or negligible GFP expression, while total thymic and liver iNKT cells were GFP + in mice of all ages examined (Fig. 2e) . The mean fluorescence intensity of GFP showed that adipose iNKT cells had very low PLZF expression compared with that of iNKT cells in thymus, liver and spleen at all ages examined; however, conventional T cells (TCRβ + cells negative for binding a tetramer of CD1d and α-galactosylceramide (α-GalCer)) in adipose tissue had even lower PLZF expression (Fig. 2f) . Thus, iNKT cells in adipose tissue expressed very little PLZF at all ages.
We next investigated the possibility that iNKT cells in adipose tissue lose PLZF expression following migration out of the thymus. Athymic nude mice, which lack all T cells, including iNKT cells, had no iNKT cells in adipose tissue (Supplementary Fig. 1 ), which confirmed the thymic origin of this iNKT cell subset. Next, to determine if iNKT cells in adipose tissue had high expression of PLZF at previous developmental stages, we crossed PLZF-Cre mice (which express a bacterial artificial chromosome transgene in which the gene encoding Cre recombinase is knocked into the gene encoding PLZF) with Rosa26 fl/fl mice (which express the fluorescent marker tdTomato and carry a loxP-flanked stop codon at the ubiquitous Rosa26 locus). In the resultant PLZF-Cre × Rosa26 fl/fl mice, cells that express PLZF (and therefore Cre) are permanently tdTomato + . iNKT cells in the spleen and adipose tissue of PLZF-Cre × Rosa26 fl/fl mice were tdTomato + (Supplementary Fig. 2 ), which indicated that iNKT cells in adipose tissue had expressed PLZF during development and downregulated its expression in the thymus or at a later stage. However, PLZF mRNA is also transiently expressed in hematopoietic stem cells and, as a result, 50% of all splenocytes, of which only 1-3% were iNKT cells in PLZF-Cre × Rosa26 fl/fl mice, were tdTomato + ( Supplementary  Fig. 2) 2, 3 . Both Plzf −/− mice and mice heterozygous for the null mutation noted above (called 'Plzf +/− mice' here) had substantially fewer thymic and peripheral iNKT cells than wild-type mice had (Fig. 2g) . We observed 50-85% fewer iNKT cells in the spleen, liver and thymus of Plzf +/− mice than in that of their wild-type littermates, while there were not significantly fewer iNKT cells in the adipose tissue of Plzf +/− mice than in that of wild-type mice (95%) (Fig. 2g) . Plzf −/− mice had 80-90% fewer iNKT cells in the spleen, liver and thymus than did wild-type mice, while the number of iNKT cells in the adipose tissue of Plzf −/− mice was 50% that of wild-type mice (Fig. 2g) . These data suggested that at steady state, iNKT cells in adipose tissue were less sensitive to genetic deletion of PLZF than were their counterparts in other peripheral sites, although homeostatic proliferation and/or survival may have compensated for PLZF deficiency specifically in adipose tissue.
We next sought to determine if iNKT cells in adipose tissue expressed the canonical α-chain variable region 14-α-chain joining region 18 (V α 14-J α 18) TCR paired with V β 7, V β 8.1 or V β 8.2. 
A r t i c l e s
Single-cell PCR analysis showed that iNKT cells in adipose tissue expressed the invariant V α 14-J α 18 TCR, paired with a limited V β repertoire ( Supplementary Fig. 3 ). Thus, our findings indicated that a population of PLZF lo iNKT cells that were less sensitive to genetic deletion of PLZF than were iNKT cells elsewhere accumulated in adipose tissue. 34 . The precursor cells at stage 0 are PLZF + , although they have a low frequency in the thymus 2 . As previously reported 2,3 , we found that the low number of iNKT cells present in the thymus and periphery of Plzf −/− and Plzf +/− mice were arrested at stage 1, on the basis of their CD44 lo NK1.1 lo phenotype (Fig. 3a) . Similar to thymic and peripheral iNKT cells from Plzf −/− and Plzf +/− mice, iNKT cells in the adipose tissue of wild-type mice were mainly CD44 lo (~80%, compared with 8-20% in the thymus and liver), and ~40% of them were NK1.1 − , in contrast to a frequency of only ~15% NK1.1 − iNKT cells in the liver (Fig. 3a,b) . Thus, iNKT cells in wild-type adipose tissue shared several key phenotypic markers with iNKT cells in PLZF-deficient liver and spleen. PLZF expression is required for the innate-like effector program of iNKT cells, including rapid production of IFN-γ after stimulation. IFN-γ production by iNKT cells is diminished or absent Microarray expression analysis showed higher expression of IL-2 mRNA by adipose iNKT cells than by iNKT cells in thymus, liver or spleen (Fig. 3c) . Furthermore, after stimulation with the phorbol ester PMA and ionomycin, iNKT cells in adipose tissue produced more IL-2 than did splenic iNKT cells (Fig. 3d) . However, after stimulation with PMA and ionomycin, IL-2 production by iNKT cells in wild-type adipose tissue was lower than that by iNKT cells in Plzf −/− adipose tissue (Fig. 3e) , which suggested that complete loss of PLZF in iNKT cells in adipose tissue had an effect on the phenotype of these cells. However, iNKT cells in wild-type adipose tissue did not express IL-2R mRNA, as assessed by RT-PCR (Fig. 3f) , or CD25 protein (data not shown), unlike splenic iNKT cells and adipose T reg cells, which had high expression of IL-2R (Fig. 3f) . Thus, iNKT cells in adipose tissue, like iNKT cells from Plzf −/− mice, had low expression of NK1.1 and CD44 and had substantial ability to produce IL-2.
Similarity of adipose i NKT cells and Plzf
Adipose i NKT cells express transcription factors T-bet and GATA-3 On the basis of their expression of the transcription factors T-bet, GATA-3 and RORγt and various cytokines, iNKT cells are grouped into the following four functional subsets: NKT1 cells, NKT2 cells, NKT17 cells [35] [36] [37] and NKT-FH cells 38 . Intranuclear staining showed that, similar to iNKT cells in the thymus, spleen and liver, iNKT cells in adipose tissue expressed GATA-3 and T-bet but had undetectable expression of RORγt (Supplementary Fig. 4a ), unlike splenic subsets of NKT17 cells (data not shown). iNKT cells in adipose tissue produce little IFN-γ after stimulation with α-GalCer in vivo or in vitro 16 . However, similar to splenic and hepatic iNKT cells, iNKT npg A r t i c l e s cells had basal expression of IFN-γ mRNA in adipose tissue (data not shown), which suggested that iNKT cells in adipose tissue were able to produce IFN-γ. To determine the cytokine-production potential of iNKT cells in adipose tissue, we stimulated total leukocytes in spleen, liver and adipose tissue for 5 h with α-GalCer or with PMA plus ionomycin and simultaneously added brefeldin A, which blocks the transport of proteins from the endoplasmic reticulum, followed by gating on CD1d tetramers and intracellular staining of cytokines. iNKT cells in adipose tissue did not produce detectable IFN-γ protein, but, unlike splenic or hepatic iNKT cells, they produced IL-10 after stimulation with α-GalCer (Supplementary Fig. 4b ). However, after stimulation with PMA plus ionomycin, adipose iNKT cells produced large amounts of IFN-γ, tumor-necrosis factor and IL-10 but little IL-4 ( Supplementary Fig. 4c ). iNKT cells in adipose tissue did not 
A r t i c l e s
produce IL-17A after stimulation either with α-GalCer or with PMA plus ionomycin (Supplementary Fig. 4c ). Thus, although adipose iNKT cells had the machinery for IFN-γ production and were able to produce IFN-γ under mitogenic conditions, they produced IL-10 but not IFN-γ when stimulated with a strong lipid ligand.
E4BP4 controls IL-10 production in adipose i NKT cells
We next investigated the transcription factors that control the expression of IL-2 and IL-10 in iNKT cells in adipose tissue. E4BP4 (encoded by Nfil3) is known to regulate IL-10 expression in T H 1 cells, T reg cells and NKT cells 6, 39 . By microarray analysis, we found high expression of E4BP4 transcripts in iNKT cells in adipose tissue but not in iNKT cells in the liver or spleen, while thymic iNKT cells had very low expression of E4BP4 transcripts (Fig. 4a) . Intranuclear staining with a monoclonal antibody showed E4BP4 expression in iNKT cells in adipose tissue but not in iNKT cells in liver, spleen, thymus, bone marrow, lymph node or blood (Fig. 4b) . T reg cells in adipose tissue also expressed E4BP4 mRNA (Fig. 4a) and E4BP4 protein, as detected by intracellular staining with monoclonal antibody to E4BP4 (Fig. 4c) , at levels similar to those of adipose iNKT cells. Conventional CD8 + T cells and (nonregulatory) CD4 + T cells did not express E4BP4 (Fig. 4d) . Flow cytometry confirmed that iNKT cells in adipose tissue were not T reg cells, on the basis of their lack of expression of the transcription factor Foxp3 (Fig. 4e) . Adipose T reg cells had high expression of IL-10 mRNA (data not shown; available at the Immunological Genome Project website), while iNKT cells in adipose tissue produced IL-10 protein following in vivo injection of α-GalCer (Fig. 4f) .
To determine if E4BP4 was required for IL-10 production in iNKT cells, we transfected in vitro-cultured primary splenic iNKT cells, which are E4BP4 − , with vector expressing E4BP4 (Fig. 4g) . E4BP4 expression induced IL-10 production in α-GalCer-stimulated splenic iNKT cells (Fig. 4h) , as measured by intracellular cytokine staining and RT-PCR, whereas mock-transfected splenic iNKT cells did not express IL-10 after stimulation (Fig. 4i) . Thus, adipose iNKT cells, unlike splenic or hepatic iNKT cells, expressed the transcription factor E4BP4, which was responsible for IL-10 production.
Regulation of adipose-resident macrophages
Through their rapid cytokine production, iNKT cells are potent transactivators of cells of the immune system and act as a bridge between innate immunity and adaptive immunity. We next investigated the effects of IL-2 and IL-10 derived from adipose iNKT cells. First, to address the localization of iNKT cells in the wild-type adipose tissue at steady state or after activation with α-GalCer, we developed a labeling technique using α-GalCer-loaded CD1d tetramers that allows detection of iNKT cells in situ in fresh tissues by confocal microscopy. Chemokine receptor CXCR6 reporter mice (in which Cxcr6 is replaced with cDNA encoding GFP) have been used to visualize hepatic iNKT cells 30 . By staining cells with α-GalCer-loaded CD1d tetramers, we confirmed that the majority (>90%) of CXCR6 + cells in adipose tissue were iNKT cells in CXCR6 reporter mice (Fig. 5a and data not shown), and we therefore used CXCR6-GFP reporter mice to image iNKT cells in the adipose tissue. We found that cells positive for CD1d tetramers (which were also CXCR6-GFP + ) were broadly dispersed throughout adipose tissue at steady state (Fig. 5a,b) , while following stimulation with α-GalCer, iNKT cells formed numerous clusters in the adipose tissue (Fig. 5a) . Costaining of wild-type mouse adipose tissue showed that iNKT cells interacted with CD11b + macrophages at steady state, particularly with CD301 + M2 macrophages (Fig. 5b) .
Following stimulation with α-GalCer, iNKT cells and CD11b + macrophages formed clusters around and between adipocytes (Fig. 5b) .
The colocalization of iNKT cells with macrophages increased from ~20% of iNKT cells at steady state to 50% of iNKT cells after treatment with α-GalCer (Fig. 5c) .
A lack of iNKT cells has been shown to induce a proinflammatory environment in adipose tissue in obesity, including increased numbers of proinflammatory macrophages 16, 20 . Furthermore, blockade of IL-10 prevents some of the beneficial effects that stimulation with α-GalCer has on metabolism 16 . To address if iNKT cell-derived IL-10 directly influences macrophage pro-or anti-inflammatory profiles in lean mice, we assessed expression of the M2 macrophage markers CD206 (mannose receptor) and CD301 (C-type lectin) and 
npg
A r t i c l e s the M1 macrophage marker CD11c on macrophages in adipose tissue 3 d after treatment of lean wild-type mice with PBS or α-GalCer.
Immunohistochemstry showed that α-GalCer induced an increase in CD206 + macrophages within 3 d compared with their abundance in PBS-treated mice (Fig. 5d) . By flow cytometry, we saw a lower frequency of CD11c + M1 macrophages in α-GalCer-treated mice than in PBS-treated mice and a significantly higher frequency of CD206 + M2 macrophages (38% versus 22%) and CD301 + M2 macrophages (50% versus 35%) in α-GalCer-treated mice than in PBS-treated mice (Fig. 5e) . Quantitative PCR analysis of whole adipose tissue showed that α-GalCer reduced the expression of mRNA encoding inducible nitric oxide synthase (iNOS) in wild-type mice but not in CD1d-deficient mice (Cd1d1 −/− ; called 'Cd1d −/− ' here) (Fig. 5f) . Furthermore, Cd1d −/− mice had more CD11c + M1 macrophages (Fig. 5g) and more iNOS + macrophages (Fig. 5h) than did wild-type mice, as measured by flow cytometry.
To determine if iNKT cell-derived IL-10 was responsible for the M2 polarization of macrophages in the adipose tissue, we neutralized IL-10 at the time of α-GalCer treatment. The decrease in the frequency of CD11c + macrophages after treatment with α-GalCer occurred independently of IL-10; however, the increase in the frequency of CD206 + and CD301 + M2 macrophages was prevented by neutralization of IL-10 (Fig. 5i) . Treatment with α-GalCer also induced the upregulation of IL-10R expression on adipose tissue macrophages, which was also prevented by neutralization of IL-10 (Fig. 5i) . Thus, iNKT cells interacted with macrophages at steady state and after stimulation with α-GalCer, and activation of iNKT cells in adipose tissue with α-GalCer induced upregulation of IL-10R expression and the M2 polarization of adipose macrophages in lean mice.
Regulation of adipose T reg cells by adipose i NKT cells T reg cells have high expression of CD25 and require IL-2 for their survival and proliferation 40 . Therefore, we investigated whether IL-2 production by iNKT cells influenced T reg cell function in the adipose tissue. First, we assessed whether in vivo stimulation of iNKT cells with α-GalCer in wild-type mice had an effect on T reg cells in adipose tissue. Three days after treatment with α-GalCer, adipose T reg cells increased in frequency (from 3% of lymphocytes to 7% of lymphocytes, and from 15% of CD4 + T cells to 30% of CD4 + T cells) and in absolute number (from 1 × 10 4 to 5 × 10 4 per two fat pads) (Fig. 6a-d) . In contrast, in the spleen, where iNKT cells do not produce IL-2, splenic T reg cell numbers did not increase after the administration of α-GalCer (Fig. 6e) . We also assessed the population expansion of T reg cells after the administration of α-GalCer 
A r t i c l e s to Foxp3-GFP reporter mice (which have sequence encoding GFP inserted into the gene encoding Foxp3). T reg cells were sparse and difficult to detect by GFP immunofluorescence in the adipose tissue of 6-to 16-week-old naive Foxp3-GFP mice (data not shown). Following the administration of α-GalCer, we observed GFP + T reg cells in iNKT cell clusters in adipose tissue (Fig. 6f) . To address whether transactivation of T reg cells occurred within the iNKT cell clusters, we quantified T reg cells in the adipose tissue of Cd1d −/− mice and J α 18-deficient mice (Tcra-J thTgi ; called 'Ja18 −/− ' here) mice at steady state. The frequency of T reg cells was significantly lower in the adipose tissue of Cd1d −/− mice (1.6% of lymphocytes) than in that of wild-type mice (4% of lymphocytes) (Fig. 6g) . Nuclear staining of the proliferation marker Ki67 showed that at steady state, T reg cells proliferated less in the adipose tissue of Cd1d −/− mice than in that of wild-type mice (Fig. 6h) . The frequency of T reg cells was also significantly lower in the adipose tissue of young and old Ja18 −/− mice than in that of their wild-type counterparts (Fig. 6i) . To determine if iNKT cell-derived IL-2 was critical for the regulation of T reg cells in the adipose tissue, we neutralized IL-2 in α-GalCer-treated wild-type mice. Blockade of IL-2 prevented the α-GalCer-induced population expansion of T reg cells in adipose tissue in vivo (Fig. 6j) . These data suggested that the activation of iNKT cells transactivated adipose T reg cells and regulated their homeostasis.
i NKT cells in adipose tissue are regulatory Next we addressed whether iNKT cells in adipose tissue induced the M2 polarization of macrophages directly or indirectly, through the activation of T reg cells and IL-10 production. Adipose tissue T reg cells have high expression of IL-10 in the resting state 18 and have higher expression of the lectin-like inhibitory receptor KLRG1 than do T reg cells in other tissues, indicative of strong anti-inflammatory and suppressive functions. KLRG1 expression is thought to be IL-2 dependent and identifies a population with enhanced suppressive function 41 . Flow cytometry showed that significantly more adipose tissue T reg cells (57%) than splenic T reg cells (5%) expressed KLRG1 protein (Fig. 7a ). An increased number of T reg cells in adipose tissue expressed KLRG1 following treatment with α-GalCer (Fig. 7a) , while significantly fewer T reg cells in the adipose tissue of Cd1d −/− mice than their wild-type counterparts expressed KLRG1 (Fig. 7a) . Furthermore, adipose T reg cells had more production of IL-10 after treatment with α-GalCer than did mice that received PBS (Fig. 7b) . At steady state, there were significantly fewer IL-10-producing T reg cells in Ja18 −/− iNKT cell-deficient mice than in wild-type mice (Fig. 7c) .
To further test the hypothesis that iNKT cells can enhance T reg cell function, we cultured peritoneal macrophages together with T reg cells freshly isolated from the adipose tissue of lean wild-type mice treated for 3 d with PBS or α-GalCer. All T reg cells in adipose tissue induced the expression of M2 markers on cultured macrophages, while T reg cells from α-GalCer-treated mice had a greater ability to induce the expression of M2 macrophage markers than did those from PBStreated mice (Fig. 7d) . These results suggested that iNKT cells were able to regulate the number and function of adipose T reg cells. We also investigated whether adipose iNKT cells could induce the M2 polarization of macrophages directly. We found that adipose iNKT cells had high expression of KLRG1 mRNA (data not shown) and more adipose iNKT cells (30%) than splenic iNKT cells (2%) had surface expression of KLRG1 (Fig. 7e) . Also, more adipose iNKT cells (7%) than splenic iNKT cells (1%) expressed the T reg cell marker ICOS, and more adipose iNKT cells (16%) than splenic iNKT cells (2%) expressed the T cell inhibitory receptor PD-1 (Fig. 7e) , which suggested that adipose iNKT cells shared some phenotypical markers with T reg cells, but splenic iNKT cells did not.
To assess the regulatory function of adipose iNKT cells, we cultured freshly isolated iNKT cells and T reg cells from wild-type mouse adipose tissues with peritoneal macrophages. iNKT cells alone were sufficient to induce the expression of M2 markers on cultured macrophages, similar to, although not as strongly as, adipose T reg cells (Fig. 7f) . iNKT cells isolated from the spleen had no regulatory potential, although splenic T reg cells did, as expected (Supplementary Fig. 5) . Culture of the peritoneal macrophages with either adipose T reg cells or iNKT cells resulted in a significantly lower frequency of iNOS-producing macrophages than did culture with medium alone (Fig. 7g) . These data indicated that adipose iNKT cells were able to directly induce M2 anti-inflammatory macrophages and also enhanced the ability of T reg cells to do the same.
DISCUSSION
Here we have described a population of PLZF neg−lo iNKT cells resident in adipose tissue that were Foxp3 − but regulatory in nature. Adipose PLZF neg−lo iNKT cells expressed E4BP4, produced IL-2 and IL-10 and controlled adipose T reg cells and macrophages locally, which made them regulators of immunity in adipose tissue. iNKT cells can act as cellular adjuvants that enhance immune responses and bridge the innate and adaptive immune systems. Although iNKT cells express a canonical TCR, they are a heterogeneous population. They respond differently under specific conditions, and have tissuespecific responses. Therefore, the ability of iNKT cells to produce various cytokines and subsequently skew an immune response is due either to the microenvironment in which they are activated or to the existence of functionally distinct NKT1, NKT2, NKT17 and NKT-FH subsets 6, 35, 37, 38 . Our findings obtained by parabiosis indicated the tissue-resident nature of adipose iNKT cells. Given their transcription factor profile, including very low PLZF levels and expression of E4BP4, adipose iNKT cells would not fall into the NKT1, NKT2, NKT17 or NKT-FH subsets previously described. A population of NKT cells in cervical lymph nodes that expresses both PLZF and Foxp3 following the administration of α-GalCer has been reported in a model of experimental autoimmune encephalomyelitis 42 , which suggests that regulatory iNKT cells can be induced in specific settings. However, we found that adipose iNKT cells did not express Foxp3. Thus, adipose iNKT cells are a distinct regulatory subset, on the basis their phenotype, transcriptional program and function.
The PLZF lo iNKT cell subset found in adipose tissue may develop toward this distinct phenotype in the thymus before migration to adipose tissue. Alternatively, this subset may represent a state of activation. iNKT cells in the rest of the body are found in a poised state, ready for rapid cytokine production following activation. Our data suggest that in contrast to iNKT cells in those other sites, adipose iNKT cells might be chronically activated. We found that at steady state, iNKT cells in adipose tissue lacked IL-7R and had high expression of CD69 and Nur77, which are hallmarks of activation through TCR stimulation 43 . In addition, cultured iNKT cell clones decrease their PLZF expression after stimulation 44 . Therefore, signals in the adipose tissue may sustain this iNKT cell subset in a chronically activated state. These signals may include lipid antigens, cytokines or adipokines that might provide costimulatory signals to iNKT cells in the presence of endogenous lipid antigens. CD1d is expressed in human adipose tissue 15 . Adipocytes themselves express CD1d 21, 22 and therefore may function as antigen-presenting cells for iNKT cells. However, if iNKT cells were chronically activated in the adipose tissue, they might be expected to be in an anergic state. Although npg A r t i c l e s more adipose iNKT cells than splenic iNKT cells expressed PD-1, our data suggested that adipose iNKT cells were not anergic, as they proliferated massively and produced cytokines in vivo after injection of α-GalCer. It has been reported that iNKT cells pretreated with α-GalCer, which are typically thought to become hyporesponsive, are still able to proliferate and produce cytokines (IL-10) 45 , which suggests these cells do not become anergic but are instead immunoregulatory subsequent to strong stimulation. The same report found enrichment for a functionally similar population in adipose tissue without α-GalCer treatment 45 , which lends strength to the hypothesis that adipose iNKT cells may be alternatively activated due to chronic stimulation locally. Adipose iNKT cells also seemed to be less dependent on PLZF expression for their development or local homeostasis than were other iNKT cell subsets. First, they expressed very little PLZF, and second, there was no significant deficiency in the number of adipose iNKT cells in Plzf +/− mice. Studies of mice with haplosufficiency of Zbtb16 have shown that high PLZF expression is required for the effector functions of other iNKT cells 2, 3, 44 and for their development, as indicated by the much lower number of iNKT cells in the periphery in Plzf +/− mice than in that of wild-type mice. It remains to be determined whether there is a compensatory mechanism in the adipose tissue of mice with haplosufficiency of Zbtb16 or whether high levels of PLZF would be required for the development, trafficking or survival of iNKT cells in adipose tissue, in a way similar to that required for iNKT cells in the liver and spleen.
Adipose tissue is a site of constant remodeling, with fluctuations in lipid handling, storage and lipolysis, due to the fasting and feeding cycles that occur in mice and humans or, in more extreme examples, during famine or obesity. The adipose-resident immune system seems to function in an anti-inflammatory state to dampen inflammation during potentially dangerous remodeling, during which foreign dietderived lipids must be tolerized and also buffered to prevent lipotoxicity. Adipocytes have an important role in buffering lipids from the immediate environment and also in preventing spillover of lipids to ectopic sites such as liver and muscle. However, the immune system, particularly macrophages, has also been linked to the prevention of lipotoxicity and the buffering of lipids 46 . We suggest that enrichment for regulatory iNKT cells in adipose tissue helps to keep inflammation at bay and at the same time helps to regulate the homeostasis of other anti-inflammatory cells of the immune system, including M2 macrophages and T reg cells.
The scenario described above fits with a protective role for adipose iNKT cells in obesity, although the beneficial role of iNKT cells in obesity is currently controversial 47, 48 due to variations in the metabolic phenotype of iNKT cell-deficient mice. However, several studies have shown that adoptive transfer of iNKT cells into obese iNKT celldeficient mice 16 or activation of iNKT cells by α-GalCer in obesity dampens inflammation, leading to improved metabolic outcome and weight loss 16, 20, 22, 27 . However, the mechanism of action of adipose iNKT cells, as well as the basis for their anti-inflammatory nature, has remained unclear. Our study sheds light on the mechanisms of action of iNKT cells in adipose tissue and therefore has implications for obesity and associated metabolic disease. The anti-inflammatory and regulatory nature of adipose iNKT cells suggests that they can influence the function of macrophages and T reg cells directly, as well as functioning as regulatory cells themselves. The observed depletion of adipose iNKT cells in human and mouse obesity 15, 16, [20] [21] [22] therefore represents the loss of a regulatory population. Without regulatory iNKT cells in adipose tissue, the number of T reg cells and the status of M2 macrophages are compromised, both of which affect the adipose tissue inflammation and metabolic disorder that accompanies obesity.
The capacity of iNKT cells to activate rapid cytokine production has been exploited to manipulate the outcomes of mouse models of autoimmunity and various cancers 8, 13, 49 . Our findings indicating that adipose iNKT cells maintained healthy adipose tissue under normal conditions suggest that these cells might be a potential therapeutic target for the correction of obesity and metabolic disorders.
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